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Abstract
p-Hydroxybenzoic acid derivatives (p-HBADs) are glycoconjugates secreted by all
Mycobacterium tuberculosis isolates whose contribution to pathogenicity remains to be
determined. The pathogenicity of three transposon mutants of M. tuberculosis deficient in the
biosynthesis of some or all forms of p-HBADs was studied. Whilst the mutants grew similarly to
the wild-type strain in macrophages and C57BL/6 mice, two of the mutants induced a more severe
and diffuse inflammation in the lungs. The lack of production of some or all forms of p-HBADs in
these two mutants also correlated with an increased secretion of the pro-inflammatory cytokines
tumour-necrosis factor α, interleukin 6 and interleukin 12 in vivo. We propose that the loss of
production of p-HBADs by tubercle bacilli results in their diminished ability to suppress the pro-
inflammatory response to infection and that this ultimately provokes extensive pulmonary lesions
in the C57BL/6 model of tuberculosis infection.
Keywords
Mycobacterium; Tuberculosis; Phenolic glycolipids; p-Hydroxybenzoic acid derivatives
© 2006 Elsevier SAS. All rights reserved.
*Corresponding author. TB Research Group, Veterinary Laboratories Agency, Woodham Lane, New Haw, Addlestone KT15 3NB,
UK. Tel.: 44 1932 341 111; fax: +44 1932 359 448. r.griffin@imperial.ac.uk (R. Griffin)..
1Present address: Department of Biochemistry, Faculty of Natural Sciences, Comenius University, Mlynska dolina CH-1, 84215
Bratislava, Slovak Republic.
Europe PMC Funders Group
Author Manuscript
Microbes Infect. Author manuscript; available in PMC 2010 October 27.
Published in final edited form as:
Microbes Infect. 2006 July ; 8(8): 2245–2253. doi:10.1016/j.micinf.2006.04.008.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
1. Introduction
It is estimated that up to two billion people are infected by Mycobacterium tuberculosis,
resulting in around eight million new cases of active disease and two million deaths every
year. The development of disease after M. tuberculosis infection depends on the genetic
background and the immune and nutritional status of the host, as well as on the nature of the
infecting strain. It is becoming apparent that different strains of M. tuberculosis trigger
different immune responses as a result of subtle differences in their cell envelope
composition, and that this substantially influences their subsequent pathogenicity [1-4].
Among the principal surface ligands that directly trigger the innate inflammatory response
are glycolipids, lipoglycans and lipoproteins which are recognised by a series of receptors
on antigen-presenting cells, including the Toll-like receptors, the mannose receptor and DC-
SIGN [5-7]. The most intensively studied mycobacterial ligand is lipoarabinomannan
(LAM). Differences in the structure of the terminal sugar moieties of LAM dramatically
influence the innate response triggered [8].
Recent interest has focused on phenolic glycolipids (PGL). They consist of a conserved lipid
core composed of phenolphthiocerol esterified by two chains of multiple methyl-branched
fatty acids (mycocerosic acids or phthioceranic acids) and a variable carbohydrate moiety
which, according to the mycobacterial species, is composed of one to four O-methylated
deoxysugars [9,10]. PGL are produced by Mycobacterium leprae, Mycobacterium kansasii,
Mycobacterium bovis, some strains of M. tuberculosis and a few other slow-growing
mycobacteria, including Mycobacterium ulcerans, Mycobacterium marinum,
Mycobacterium gastri, Mycobacterium microti and Mycobacterium haemophilum. PGL-1
from M. leprae has been the most extensively studied phenolphthiocerol glycolipid. It has a
plethora of effects on the immune system; from a role in the uptake of bacteria by Schwann
cells and mononuclear phagocytes to suppressive effects on monocytic and
lymphoproliferative responses [9-16]. Interestingly, many of the biological activities of
PGL-1 are specifically associated with the carbohydrate moiety of this molecule.
The role of M. tuberculosis PGL (PGL-tb) (Fig. 1) in the pathogenesis of tuberculosis is less
clear. In spite of the finding that the hypervirulence of a W-Beijing isolate of M.
tuberculosis was associated with the presence of PGL-tb in this strain [3,17] most strains of
the tubercle bacillus do not produce PGL due to a frameshift mutation in the polyketide
synthase gene pks15/1, which is required for the assembly of the lipid moiety of the
molecule [11]. However, all M. tuberculosis isolates analysed to date have retained the
ability to produce and secrete p-Hydroxybenzoic acid derivatives (p-HBADs)-
glycoconjugates which share with PGL-tb the same glycosylated aromatic nucleus [11] (Fig.
1). Since p-HBADs may themselves be biologically active species, as is the case with the
glycosylated aromatic nucleus of PGL-1, we set out to explore the role of p-HBADs in the
pathogenicity of M. tuberculosis. To this end, we used a PGL-deficient strain (with a natural
frameshift in pks15/1) and compared the pathological and immunological behaviour of M.
tuberculosis mutants deficient in the production of some or all forms of p-HBADs, derived
from this strain, in vitro and in vivo.
2. Materials and methods
2.1. Bacterial strains and culture conditions
Mt103, the clinical isolate of M. tuberculosis used in this study and the mutants 7B7, 66C7
and 29D6 were grown in ADC-supplemented Middlebrook 7H9 medium (Difco), minimal
Sauton’s medium as surface pellicles or on solid, OADC-supplemented Middlebrook 7H11
medium (Difco). Where indicated, kanamycin (Kan) and hygromycin (Hyg) were added to
final concentrations of 25 μg/ml and 50 μg/ml, respectively.
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2.2. Screening of a M. tuberculosis Mt103 transposon mutant library with the monoclonal
antibody CS-35
The M. tuberculosis Mt103 ordered transposon mutant library screened in this study is the
one described earlier [18]. To rapidly identify mutants of M. tuberculosis with defects in
LAM synthesis or transport, the anti-LAM antibody CS-35 [19] was used to detect by
immuno-dot-blotting those mutants with loss of or reduced binding to the antibody. When
interpreting the results, the density of culture sampled from each mutant was taken into
consideration. For example, mutants that showed no reactivity and also no growth upon sub-
culturing the library were discounted.
2.3. Identification of the transposon insertion sites
The transposon insertion site in each mutant was identified by ligation-mediated PCR [20].
2.4. Complementation studies
We previously described the complementation of mutant 66C7 [21]. The same PCR
conditions and the same vector were used for the amplification, cloning and expression of
Rv2958c and Rv2959c to complement 7B7 and 29D6, as were used for the complementation
of 66C7. Specifically primers Rv2958c.1 (5′-ccgcgcccatatggaggaaacaagcgtcgcc-3′) and
Rv2958c.2 (5′-gaaaggatgcatgcagacgagccgcagcgcac-3′), incorporating NdeI and NsiI
restriction sites (underlined), and Rv2959c.1 (5′-cgggttaatggggctagtgtggcgcagtc-3′) and
Rv2959c.2 (5′-cccaagcttgttgcggatcagaaatccgttgg-3′), incorporating MseI and HindIII sites,
were designed to amplify the entire genes, Rv2958c and Rv2959c, respectively, for direct
cloning into the NdeI/PstI and NdeI/HindIII sites of pVV16. The production of the
recombinant Rv2958c and Rv2959c proteins in the complemented mutants was analysed by
Western blotting with a mouse monoclonal anti-His antibody (Penta-His antibody, Qiagen).
2.5. Biochemical analyses of M. tuberculosis mutants
For flow cytometry analyses of whole cells, bacteria grown in 7H9 were harvested by
centrifugation and washed twice with PBS containing 2% FCS (PBS-FCS). Washed cells
were alternatively heat-killed or used directly for labelling. Cells were incubated in PBS-
FCS containing the monoclonal antibody CS-35 for 1 h at 4 °C. Cells were then washed
twice and incubated in PBS-FCS containing a rabbit anti-mouse Cy3-conjugated secondary
antibody. After 1 h of incubation at 4 °C, cells were washed, resuspended in 5% PFA in PBS
and analysed with a FACSCalibur™ 1506 System (Becton Dickinson).
For all other analyses, bacterial strains were grown in Sauton’s medium. Lipomannan (LM)
and LAM were extracted from disrupted bacterial cells by reflux in 40% aqueous ethanol at
60 °C. After centrifugation at 4000 rpm for 30 min, the extracts were filtered through 0.2
μm-pore size filters (Sarstedt), evaporated to dryness and finally resuspended in milli-Q
water. LM and LAM extracted from bacterial cells were analysed by SDS-PAGE
fractionation and silver staining and by Western analysis using the CS-35 Mab. The
monosaccharide content of the LM and LAM extracted from bacterial cells and that of
culture filtrates (containing arabinomannan, glucan and mannan) were analysed by capillary
zone electrophoresis as described [22] and related to the amounts of dried cells. p-HBAD
production was investigated by thin-layer chromatography (TLC) analysis of total lipids
extracted from bacterial cells and culture media as previously described [21].
2.6. Purification and structural analysis of glycoconjugate G2
G2 was purified from the culture filtrate of the complemented strain 7B7/pVVRv2958c by
preparative TLC using CHCl3/CH3OH/H2O (90:10:1, vol:vol:vol) as the eluent.
Methanolysis and trimethylsilyl (TMS) derivatization of glycoconjugate G2 were carried out
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as described [21]. The TMS derivatives were solubilized in either petroleum ether, for gas
chromatography (GC) and GC-mass spectrometry (GC-MS), or in chloroform for MALDI-
TOF mass spectrometry. MALDI-TOF mass spectrometry, GC and GC-MS analyses were
performed as described [11,21]. NMR spectra were recorded on an Avance Bruker
spectrometer equipped with a 600 MHz cryoprobe and with topspin 1.3 software system.
The sample was dissolved in CDCl3 (99.96 atom % D) and analysed in 5 mm NMR
tubes. 1H spectra were recorded at 295 K; 1H chemical shifts were expressed with respect to
the internal CDCl3 (at 7.27 ppm).
2.7. Infection of mice
6- to 8-week-old female C57BL/6 mice were infected intravenously with 105 CFU of M.
tuberculosis wild-type and mutant strains as described [23]. Five mice were used per
experimental time point and per strain.
2.8. Histopathological assessment of mice lungs
For histopathology studies, four additional mice were infected in each experimental group.
Lungs from killed mice were aseptically removed. The superior, median and inferior lobes
of the lungs were fixed in 3.7% neutral-buffered formaldehyde for two days and embedded
in paraffin (melting fusion point, 60 °C). Serial 5 μm sections were then cut and stained with
hematoxylin-eosin or by the Ziehl-Neelsen procedure. Inflammatory lesions within the
alveolae, bronchus wall, vessels and pleural effusions were studied. The surface of
granulomas was calculated using the Leica QWin program (Leica Microsystems Imaging
Solutions Ldt.). Sections were blindly evaluated by a pathologist.
2.9. Preparation and infection of murine bone marrow macrophages (BMMs)
BMMs were prepared from the femurs and tibias of 6- to 8-week-old C57BL/6 mice
(CERJanvier, France) and infected as described [23]. Macrophages were seeded in 12-well
plates (5 × 105 cells per well) and allowed to differentiate for 7 days. All infections (MOI of
0.1 bacilli per cell) were carried out at 37 °C in a 5% CO2 atmosphere.
2.10. Cytokine analysis
Cytokine secretion by macrophages was tested by infecting cells with M. tuberculosis at 10
bacilli per cell and harvesting culture supernatants 24 and 48 h after infection. The
supernatants were sterile filtered and analysed for the presence of cytokines and chemokines
(IL-12, IL-6, TNFα, IL-10) by cytometric bead array technology (BD Biosciences) and
ELISA as described earlier [2].
3. Results
3.1. Isolation of p-HBAD mutants from a transposon library of M. tuberculosis
In the course of an initial investigation on LAM, we screened over 6000 transposon mutants
of M. tuberculosis Mt103 with the monoclonal antibody CS-35 to identify mutants with
altered expression of surface LAM. Twenty-five mutants showing reduced antibody binding
were selected, and the insertion site of the transposon was mapped for each of these (Table
1). Unexpectedly, we found that in three of the mutants, 7B7, 29D6 and 66C7, insertions
had occurred in a region of the genome associated with PGL synthesis. Specifically, the
transposons were inserted 17 base pairs upstream from the start codon of the
glysosyltransferase gene Rv2958c in 7B7, 666 bp downstream from the predicted start
codon of the methyltransferase gene Rv2959c in 29D6 and 237 bp downstream from the
start codon of the chorismate pyruvate-lyase gene Rv2949c in 66C7. We confirmed that the
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transposon insertion abolished the expression of Rv2958c in 7B7 by RT-PCR (data not
shown).
3.2. Biochemical analyses of the mutant strains
To further characterise the binding of the mutants to CS-35, we performed FACS analysis
on each of the mutant strains. With this approach, we observed no difference in the overall
binding of the mutants compared to the wild-type strain to CS-35, indicating that the
mutants exposed at their surface the same amount of LAM as Mt103 (data not shown).
Using different analytical methods (see Section 2.5), we then compared the LAM and LM
contents as well as the monosaccharide contents of the LAM and LM fraction and culture
filtrates from 7B7, 29D6, 66C7 and wild-type M. tuberculosis Mt103. Again, no quantitative
or qualitative differences were observed. Taken together, these results show that the
mutations in 7B7, 29D6 and 66C7 do not affect LAM biosynthesis. We therefore have to
conclude that the transposon insertions in the mutants had some effect either on exposure of
LAM on the cell surface or attachment of mycobacterial cells to the nitrocellulose
membrane used in the initial screen. The absence of any obvious differences in CS-35
antibody binding as assessed by flow cytometry on both live and heat-killed wild-type and
mutant strains favours the latter explanation.
Since the insertions in 7B7, 29D6 and 66C7 are close to the pks15/1 gene implicated in PGL
biosynthesis, we next investigated the production of PGL and related p-HBAD molecules in
the mutants. As expected for a M. tuberculosis strain carrying the pks15/1 mutation, the
parent strain, Mt103, is devoid of PGL, but releases into the culture medium the mono- and
tri-glycosylated p-Hydroxybenzoic acid methyl esters, p-HBAD-I and p-HBAD-II (Figs. 1
and 2). In addition, Mt103 secretes into the culture medium two other related
glycoconjugates (Fig. 2). One of them was found to co-migrate with a rhamnosyl-α-p-
hydroxybenzoic acid methyl ester standard and thus corresponds to an unmethylated form of
p-HBAD-I (UM-p-HBAD-I) [21]. The second glycoconjugate (G1) migrating close to the
origin (Fig. 2) was recently characterised as 2-O-methyl-fucosyl-α-(1 → 3)-rhamnosyl-α-(1
→ 3)-2-O-methyl-rhamnosyl-α-p-hydroxybenzoic acid methyl ester, a truncated form of p-
HBAD-II lacking two methyl groups on the fucosyl residue [21].
7B7, in contrast, secreted only the mono-glycosylated p-HBAD-I and UM-p-HBAD-I into
the culture medium (Fig. 2). There was no evidence for the production of p-HBAD-II or
related glycoconjugate G1 in either the culture medium (Fig. 2) or in the bacterial cells of
this mutant. Consistent with this observation, a recent publication [24] proposed that
Rv2958c encodes the glycosyltransferase involved in the addition of the second rhamnosyl
residue in p-HBAD-II and PGL (Fig. 1).
Unmethylated p-HBAD-I (UM-p-HBAD-I) was the only form of p-HBAD recovered from
the culture filtrate of 29D6 (Fig. 2). This result is consistent with the recent characterisation
of Rv2959c as the methyltransferase involved in the O-methylation of the hydroxyl group
located at position 2 of the first rhamnosyl residue found in p-HBAD and PGL [25]. We
recently reported the biochemical phenotype of 66C7 [21]. This mutant is totally deficient in
the production of p-Hydroxybenzoic acid and consequently lacks all forms of p-
hydroxybenzoate derivatives (Fig. 2). Further thin-layer chromatography analyses using a
variety of solvents revealed no other qualitative or quantitative difference between the lipid
contents of Mt103 and the mutants (data not shown).
3.3. Complementation of the mutants restores p-HBAD synthesis
7B7, 29D6 and 66C7 were complemented with wild-type copies of the Rv2958c, Rv2959c
and Rv2949c genes respectively.
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As described earlier, the complementation of 66C7 with plasmid pVVRv2949c restored the
production of all forms of p-HBAD normally found in the wild-type strain [21].
Complementation of 7B7 restored both the production of p-HBAD-II and that of the
partially methylated form of p-HBAD-II (G1) in the mutant (Fig. 2). However, probably due
to the strong expression of Rv2958c in 7B7pVVRv2958c, all of the p-HBAD-I produced by
the complemented strain was further glycosylated into p-HBAD-II, as no p-HBAD-I could
be detected in the culture filtrates of 7B7pVVRv2958c. Interestingly, the complemented
strain also accumulated a new glycoconjugate (G2), exhibiting a lower mobility than p-
HBAD-II, which was not detected in the parent strain Mt103 (Fig. 2). This product was
purified by preparative TLC and its native and derivatized forms were analyzed by a
combination of MALDI-TOF mass spectrometry, GC, GC-MS and NMR as described in
section 2.6. These analyses established that the most likely structure of compound G2 is a
tri-glycosylated form of p-HBAD in which the trisaccharide part consists of tri-O-methyl-α-
L-Fucp-(1 → 3)-a-L-Rhap-(1 → 3)-α-L-Rhap (data not shown). It is likely that this product
results from the direct glycosylation of UM-p-HBAD-I (without prior methylation), as a
result of the over-expression of Rv2958c in the complemented strain.
Complementation of 29D6 with pVVRv2959c restored the synthesis of p-HBAD-I, p-
HBAD-II and that of the glycoconjugate G1 in the mutant, although the quantities of tri-
glycosylated forms of p-HBAD (p-HBAD-II and G1) relative to p-HBAD-I were less than
in the parent strain.
3.4. p-HBAD mutants show similar growth to the wild type strain in cultured macrophages
and in mice
The growth rate of M. tuberculosis strains Mt103, 7B7, 29D6 and 66C7 in 7H9 broth was
comparable (data not shown). Likewise, the mutants were found to grow similarly to the
wild-type Mt103 in resting C57BL/6 bone marrow-derived macrophages (BMMs) over a 9-
day period (Fig. 3). The ability of the wild-type and mutant strains to replicate and persist in
the lung and spleen of C57BL/6 mice was then studied after intravenous infection of 105
CFU. As shown on Fig. 4, the bacterial load in the spleens and lungs of mice infected with
the mutants were comparable to those infected with the parent strain over 90 days.
3.5. p-HBAD mutants show histological differences in lung tissue of infected mice
In spite of bacillary loads remaining similar between all the strains, the pulmonary lesions
induced by some of the mutants were significantly different from those induced by the
parent strain. Forty-two days post-infection, while chronic lesions were observed in all
groups of mice, the most severe lesions were observed with strain 7B7 (Fig. 5). The group of
mice infected with this mutant showed diffuse and extensive lobular infiltrates containing
large macrophages aggregated with lymphocytes. In addition to these symptoms of an acute
inflammatory reaction, there was substantial local recruitment of polymorphonuclear cells as
well as extensive and diffuse alveolitis extending to the pleural membrane. In comparison,
the lesions induced by the wild-type strain Mt103 or by 29D6 displayed well-organised and
mature granuloma-like structures containing large histiocytes associated with lymphocytes,
with no extension to the pleural membrane, no or few polymorphonuclear cells and no
vascular lesions (Fig. 5). 66C7-infected mice displayed an intermediate phenotype with a
slightly more intense and diffuse inflammatory reaction than in Mt103-infected mice (Fig.
5). In agreement with the histological analysis, granuloma-like structures in the lungs of
7B7-, 66C7-, Mt103- and 29D6-infected mice 42 days post-infection occupied
approximately 32, 27, 25 and 24% of histological sections, respectively.
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3.6. Modulation of macrophage cytokine responses by p-HBAD mutants
To explore the mechanism by which the defects in the production of p-HBADs might
contribute to the changes in gross histopathology of the lung, we compared pro-
inflammatory cytokine production in C57BL/6 BMMs infected with Mt103 and each of the
mutants. In all experiments, we confirmed that the number of phagocytosed bacteria was
equivalent for all strains by plating CFU from additional control wells.
7B7 and 66C7 induced the secretion of significantly higher amounts of IL-6 and TNFα
compared to Mt103 (Fig. 6) with typical increases of 2–2.5-fold for TNFα. 7B7 also caused
a significant increase in IL-12 production (Fig. 6). 29D6 behaved similarly to Mt103.
Interestingly, the complemented mutant strain 7B7pVVRv2958c showed reversion of each
of the cytokine profiles generated by 7B7 beyond that of the wild-type strain. This is likely
due to the strong over-expression of Rv2958c in the complemented mutant, which directly
affects the ratio of the tri-glycosylated forms of p-HBADs relative to the monoglycosylated
forms (Fig. 2). Complementation of 66C7 with the wild-type copy of the Rv2949c gene
restored the secretion of wild-type levels of IL-6 and TNFα (data not shown).
4. Discussion
The intriguing observation that most M. tuberculosis isolates fail to produce the virulence-
associated PGL-tb while all strains analyzed to date have retained the ability to synthesize
the glycosylated aromatic nucleus of these glycolipids, prompted us to study the role of p-
HBADs in the pathogenesis of tuberculosis. To this end, the pathogenicity and
immunogenicity of three mutants of M. tuberculosis Mt103 with defects in different aspects
of p-HBAD synthesis were compared in macrophage and mouse models of infection.
None of the mutants, including 66C7, which is totally deficient in p-HBAD synthesis,
showed any significant difference in growth in C57BL/6 mice and in macrophages
compared to Mt103. However, there were appreciable differences in the lung histology of
these mice. 7B7 and, to a lesser extent, 66C7 induced a significantly more severe and diffuse
inflammation than Mt103. We conclude that the production of p-HBADs by M. tuberculosis
strains has a significant impact on the host response to infection.
Our in vivo data suggest that this might initially be mediated through changes in the innate
immune response of the host. Recognition of mycobacterial ligands by innate immune
receptors on antigen-presenting cells results in activation of antimicrobial activities and
release of cytokines that attract other immune cells and promote a Th1 adaptive immune
response with production of IFNg and increased macrophage activation. IL-6, IL-12 and
TNFα are among the major cytokines required for pro-inflammatory responses, granuloma
formation and development of a type 1 response during tuberculosis [26-28]. However, M.
tuberculosis has evolved mechanisms to suppress this pathway permitting its survival and
growth in macrophages [29]. The results of the present study demonstrated that failure to
produce some or all forms of p-HBADs has the effect of reducing this suppression of innate
immunity, thereby permitting increased production of IL-6, IL-12 and TNFα by
macrophages.
The observation that our mutants differing solely in the carbohydrate moiety of these
molecules induced different cytokine profiles suggests that at least some forms of p-HBADs
do indeed play a role in this process. However, given the complex pattern and variable ratios
of p-HBAD species secreted by the different strains analysed in the present study (Fig. 2),
one cannot readily attribute a specific immunomodulatory activity to any given p-HBAD
molecule. In the same way different types of PGL molecules induce different cytokine
Stadthagen et al. Page 7
Microbes Infect. Author manuscript; available in PMC 2010 October 27.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
responses by murine macrophages [3] it is likely that each different p-HBAD molecule, or
strain-specific cocktail of p-HBAD molecules, causes distinct, even antagonist cytokine
responses. Hence, the different cytokine levels observed upon infection of macrophages with
the mutants reflect the overall response to the different p-HBADs cocktails generated by
each individual strain.
A recent study suggested that the production of di- and tri-glycosylated p-HBADs conferred
upon M. tuberculosis H37Rv an increased resistance to IFNγ-dependent but iNOS-
independent immune antimicrobial pathways [30]. Our study suggests additional roles for p-
HBADs in host infection and provides the first evidence that p-HBAD production by M.
tuberculosis influences the release of key inflammatory cytokines by macrophages. We
propose that the diminished ability of 66C7 and 7B7 to suppress the pro-inflammatory
response results in severe pathology in the lungs of C57BL/6 mice due to the over-
stimulation of the naturally strong basal immune immune response elicited by this strain of
mouse. Next, it would be interesting to study the behaviour of the p-HBAD mutants in a
mouse model exhibiting a less robust immune response to M. tuberculosis than C57Bl/6
mice. In a more susceptible mouse model, the anticipated enhanced stimulation of
proinflammatory cytokines in response to the mutants may lead to improved control of
infection and may reveal differences between the mutants in bacterial growth.
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Fig. 1.
Model structures of PGL, p-HBAD-I and p-HBAD-II from M. tuberculosis. The lipid core
of PGL is composed of phenolphthiocerol esterified by mycocerosic acids (m = 15–17; n =
20–22, n’, n” = 16, 18; p, p’ = 2–5; R = −CH2−CH3 or −CH3). The trisaccharide substituent,
also found in p-HBAD-II, consists of 2,3,4-tri-O-methyl-α-L-Fucp-(1 → 3)-α-L-Rhap-(1 →
3)-2-O-methyl-α-L-Rhap. The monosaccharide substituent found in p-HBAD-I consists of 2-
O-methyl-α-L-Rhap. The sites of action of the glycosyltransferase encoded by Rv2958c, of
the methyltransferase encoded by Rv2959c and of the chorismate pyruvate-lyase encoded by
Rv2949c are indicated by arrows.
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Fig. 2.
Thin-layer chromatography analysis of lipids extracted from the culture supernatants of M.
tuberculosis strains Mt103, 7B7, 29D6, 66C7 and the complemented mutant strains,
7B7pVVRv2958c, 29D6pVVRv2959c and 66C7pVVRv2949c. Equal volumes of lipid
preparations extracted from the culture filtrates of each strain were applied to TLC plates,
developed in CHCl3/CH3OH (95:5) and revealed with α-naphthol. The positions of p-
HBAD-I, p-HBAD-II are indicated by arrows.
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Fig. 3.
Growth of M. tuberculosis Mt103 and p-HBAD mutants in resting C57BL/6 bone-marrow-
derived macrophages. The multiplicity of infection used is 1:10 bacterium per macrophage.
The reported values represent the mean and standard deviation (error bars) of data obtained
from three independent wells in one typical experiment. Wild-type Mt103 (diamonds); 7B7
(squares); 29D6 (crosses); 66C7 (triangles). Infection experiments were carried out in
triplicate using three independent batches of bacterial preparations.
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Fig. 4.
Multiplication and persistence of Mt103 wild-type and p-HBAD mutant strains in the lungs
and spleen of intravenously-infected C57BL/6 mice. Results are expressed as means ±
standard deviations (error bars) of CFU counts for five infected mice. Wild-type Mt103
(diamonds); 7B7 (squares); 29D6 (crosses); 66C7 (triangles).
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Fig. 5.
Typical pulmonary granuloma at 42 days post-infection from C57BL/6 mice infected with
either M. tuberculosis Mt103, 7B7, 29D6 or 66C7. Sections were stained with hematoxylin
and eosin. Left panels, magnification ×20. Right panels, magnification ×200. More lobular
infiltrates (arrows) are seen in 7B7-infected mice with pleural effusion and numerous
polymorphonuclear cells (arrowheads).
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Fig. 6.
Cytokine secretion by C57BL/6 bone marrow-derived macrophages in response to infection
with Mt103, 7B7, 29D6, 66C7 and 7B7 complemented strains. Supernatants of infected
macrophages were assayed for the production of cytokines 24 (black bars) and 48 h (white
bars) post-infection. Values represent the means ± standard deviations (error bars) of
cytokine production measured in three independent wells in one typical experiment. An
asterisk indicates P values <0.05 (Student’s t test) for the comparison of wild-type vs mutant
strains. Cytokine production was measured in three independent experiments using fresh cell
and bacterial preparations.
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Table 1
Location of transposon and predicted function of disrupted genes in 25 transposon mutants of M. tuberculosis,
including the three strains investigated in this study
Mutant
designation
M. tuberculosis
H37Rv Gene ID
Position of
insertiona
Gene function
7B7 Rv2958c −17 bp Glycosyltransferase
29D6 Rv2959c +666 bp Methyltransferase
66C7 Rv2949c +237 bp Chorismate pyruvate-lyase
43G6 Rv1502 +657 bp Unknown; close to several
glycosyltransferase genes
18G7 Rv0193c +392 bp Unknown
25E7 Rv1948c +32 bp Unknown
5C2 Rv2020c +295 bp Unknown
23D4 intergenic region
in RvD2
– Unknown
41F5 Rv3480c −54 bp Unknown
44B5 Rv2387 −297 bp Unknown
34D6 Rv2338c (moeW) +920 bp Possible molybdopterin
biosynthesis protein
33G4 Rv2338c (moeW) +383 bp Possible molybdopterin
biosynthesis protein
7H10 Rv2339 (mmpL9) +311 bp Probable transmembrane
transport protein
41E5 Rv2339 (mmpL9) +1542 bp Probable transmembrane
transport protein
28H4 Rv0987 +1592 bp Probable transmembrane
protein ABC transporter
3A10 Rv3500c (yrbE4B) +605 bp Membrane protein
3F7 Rv0304c (ppe5) +6598 bp PPE family protein
2G7 Rv3343c (ppe54) +2594 bp PPE family protein
35D3 Rv1548c (ppe21) +1073 bp PPE family protein
31D7 Rv0112 (gca) +329 bp Possible GDP-mannose 4,
6 dehydratase
20H5 Rv0449c +520 bp Putative dehydrogenase
24F7 Rv0456c (echA2) −700 bp echA2, enoyl-CoA
hydratase;
59D7 Rv1664 (pks9) +3017 bp Unknown polyketide
synthase
34B8 Rv3825c (pks2) +3213 bp Polyketide synthase
(sulfolipid synthesis)
35B10 Rv2368c +568 bp Probable PhoH-like protein
a
Position of insertion relative to the predicted start codon of the gene (http://genolist.pasteur.fr/TubercuList/). Negative values indicate that the
transposon is inserted in an intergenic region upstream from the start codon of the indicated gene.
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